10.14

5.19% 0.50

Precipio Inc (PRPO)

Overview News Price History Financials Discussions Forecast Stock Split

Precipio Inc stock is traded at $10.14, with a volume of 77,537. It is up +5.19% in the last 24 hours and up +52.25% over the past month. Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Previous Close:

$9.64

Open:

$10.21

24h Volume:

77,537

Relative Volume:

9.14

Market Cap:

$15.03M

Revenue:

$15.81M

Net Income/Loss:

$-4.90M

P/E Ratio:

-2.9649

EPS:

-3.42

Net Cash Flow:

$-2.65M

1W Performance:

+40.40%

1M Performance:

+52.25%

6M Performance:

+57.94%

1Y Performance:

+59.69%

1-Day Range:

$9.45

$10.74

1-Week Range:

$7.26

$10.74

52-Week Range:

$4.31

$10.74

Precipio Inc Stock (PRPO) Company Profile

Name

Precipio Inc

Sector

Healthcare (1169)

Industry

Diagnostics & Research (60)

Phone

203 787 7888

Address

12325 EMMET ST, OMAHA, CT

Employee

Twitter

@precipiodx

Next Earnings Date

2024-11-11

Latest SEC Filings

PRPO's Discussions on Twitter

Compare PRPO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRPO Precipio Inc	10.14	15.03M	15.81M	-4.90M	-2.65M	-3.42
TMO Thermo Fisher Scientific Inc	532.55	203.70B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	210.23	151.18B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	135.37	38.62B	6.51B	1.29B	1.37B	4.42
IDXX Idexx Laboratories Inc	452.77	37.07B	3.90B	887.87M	808.08M	10.67
IQV Iqvia Holdings Inc	191.04	33.64B	15.41B	1.37B	2.11B	7.50

Precipio Inc Stock (PRPO) Latest News

03:48 AM

(PRPO) Trading Report - Stock Traders Daily

03:48 AM

Feb 20, 2025

Investors Still Aren't Entirely Convinced By Precipio, Inc.'s (NASDAQ:PRPO) Revenues Despite 28% Price Jump - Simply Wall St

Feb 20, 2025

Feb 19, 2025

Precipio Announces Q3-2019 Corporate Update Call for Shareholders - ACCESS Newswire

Feb 19, 2025

Feb 14, 2025

PRPO stock touches 52-week high at $7.42 amid market optimism - MSN

Feb 14, 2025

Precipio (NASDAQ:PRPO) Stock Passes Above Two Hundred Day Moving Average – Time to Sell? - Defense World

Feb 14, 2025

Feb 11, 2025

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 - br.ADVFN.com

Feb 11, 2025

Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results - br.ADVFN.com

Feb 11, 2025

PRPOPrecipio Granted 180 Day NASDAQ Extension to Regain Compliance - br.ADVFN.com

Feb 11, 2025

(PRPO) Proactive Strategies - Stock Traders Daily

Feb 11, 2025

Jan 23, 2025

Precipio Grants Options to Officers as Part of Long-Term Incentive Equity Program - Defense World

Jan 23, 2025

Jan 22, 2025

Precipio announces executive option grants tied to stock performance - Investing.com India

Jan 22, 2025

Jan 21, 2025

Precipio announces executive option grants tied to stock performance By Investing.com - Investing.com UK

Jan 21, 2025

Jan 17, 2025

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs - The Manila Times

Jan 17, 2025

Jan 16, 2025

Precipio Adopts Performance-Based Stock Options for 2025 - TipRanks

Jan 16, 2025

Precipio Management Bets Big: Opts for Stock Options That Only Vest at $30 Share Price - StockTitan

Jan 16, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jan 16, 2025

The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio - Yahoo Finance

Jan 16, 2025

Jan 15, 2025

Top Research Reports for Visa, AbbVie & Analog Devices - Yahoo Finance

Jan 15, 2025

Dec 30, 2024

(PRPO) Trading Advice - Stock Traders Daily

Dec 30, 2024

Dec 20, 2024

Investors Aren't Entirely Convinced By Precipio, Inc.'s (NASDAQ:PRPO) Revenues - Simply Wall St

Dec 20, 2024

Dec 19, 2024

PRPO (Precipio) 3-Year Book Growth Rate : -14.20% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024

How to Take Advantage of moves in (PRPO) - Stock Traders Daily

Nov 28, 2024

PRPO (Precipio) 3-Year EPS without NRI Growth Rate : 28.00% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024

PRPO (Precipio) 3-Year EBITDA Growth Rate : 32.10% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024

PRPO (Precipio) 3-Year Revenue Growth Rate : 16.60% (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024

Nov 25, 2024

PRPO (Precipio) Future 3-5Y Total Revenue Growth Rate : N/A (As of Nov. 26, 2024) - GuruFocus.com

Nov 25, 2024

PRPO (Precipio) Growth Rank : 3 (As of Nov. 25, 2024) - GuruFocus.com

Nov 25, 2024

Two Smaller Companies Worthy of Your "Attention" - Yahoo Finance

Nov 25, 2024

PRPO (Precipio) 3-Year FCF Growth Rate : 32.40% (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 23, 2024

PRPO (Precipio) GF Value Rank : 2 (As of Nov. 23, 2024) - GuruFocus.com

Nov 23, 2024

PRPO (Precipio) Debt-to-Equity : 0.11 (As of Sep. 2024) - GuruFocus.com

Nov 23, 2024

Nov 20, 2024